Parkinson's Disease Trial, Recruiting NCT05800470 Sponsor: National Yang Ming Chiao Tung University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05800470
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For Part 1:

  • People who have been diagnosed with Parkinson's disease (the kind that doesn't have a known cause) by a neurologist, and whose condition is not at the most severe stage
  • People who are in a stable overall health condition
  • People who are able to walk on their own without any walking aids (such as a cane or walker)

For Part 2:

  • People aged between 40 and 85 years old
  • People who have been diagnosed with Parkinson's disease (the kind that doesn't have a known cause) by a neurologist, and whose condition is not at the most severe stage
  • People who are in a stable overall health condition
  • People who are able to walk independently for at least 10 minutes without stopping

Who may not be able to join:

For Part 1:

  • People who show signs of significant memory or thinking difficulties, based on a standard cognitive test score below a certain level
  • People who score below a certain level on a test that measures the ability to mentally picture movements in the mind
  • People who are not able to recognise the 26 letters of the English alphabet
  • People who have a history of conditions that could interfere with the study, such as epilepsy, metal implants in the brain, or deep brain stimulation devices
  • People who have been diagnosed with another neurological condition or mental health disorder, such as stroke, anxiety disorder, or depression
  • People who have been taking medications that affect the brain or nervous system (other than those prescribed for Parkinson's disease) in the past 3 months

For Part 2:

  • People who show signs of significant memory or thinking difficulties, based on a standard cognitive test score below a certain level
  • People who have a history of conditions that could interfere with the study, such as epilepsy, metal implants in the brain, or deep brain stimulation devices
  • People who have been diagnosed with another neurological condition or mental health disorder, such as stroke, anxiety disorder, or depression
  • People who have been taking medications that affect the brain or nervous system (other than those prescribed for Parkinson's disease) in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ray-Yau Wang, National Yang Ming Chiao Tung University

Phone: +88628267210

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Yang Ming Chiao Tung University
Registry
ClinicalTrials.gov
Start date
19 March 2025
Est. completion
1 August 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Self-perceived fatigue for general fatigue level; Motor imagery ability; Kinesthetic and visual imagery ability; Self-perceived fatigue for concurrent fatigue level; Change of Mini Balance Evaluation Systems Test (Mini-BEST) from pre-test to post-test; Change of Mini Balance Evaluation Systems Test (Mini-BEST) from pre-test to follow-up; Change of Timed up-and-go test (TUG) from pre-test to post-test; Change of Timed up-and-go test (TUG) from pre-test to follow-up; Change of gait performance from pre-test to post-test; Change of gait performance from pre-test to follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov